Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by Wills Eye
Sponsor:
Collaborator:
University of Medicine and Dentistry of New Jersey
Information provided by (Responsible Party):
Dr. Alex V. Levin, MD, MHSc, Wills Eye
ClinicalTrials.gov Identifier:
NCT01533376
First received: February 11, 2012
Last updated: December 18, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)